Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H13ClN2O2 |
Molecular Weight | 300.74 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C(C=C(Cl)C=C2)N(C3=CC=CC=C3)C(=O)CC1=O
InChI
InChIKey=CXOXHMZGEKVPMT-UHFFFAOYSA-N
InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3
Molecular Formula | C16H13ClN2O2 |
Molecular Weight | 300.74 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:11:45 UTC 2023
by
admin
on
Fri Dec 15 15:11:45 UTC 2023
|
Record UNII |
2MRO291B4U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
2751
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
||
|
FDA ORPHAN DRUG |
248307
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
||
|
LIVERTOX |
NBK548865
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
||
|
WHO-ATC |
N05BA09
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
||
|
NCI_THESAURUS |
C28197
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
||
|
WHO-VATC |
QN05BA09
Created by
admin on Fri Dec 15 15:11:46 UTC 2023 , Edited by admin on Fri Dec 15 15:11:46 UTC 2023
|
||
|
NDF-RT |
N0000175694
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
22316-47-8
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
31413
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
CLOBAZAM
Created by
admin on Fri Dec 15 15:11:46 UTC 2023 , Edited by admin on Fri Dec 15 15:11:46 UTC 2023
|
PRIMARY | |||
|
C012255
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
DTXSID2046759
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
2789
Created by
admin on Fri Dec 15 15:11:46 UTC 2023 , Edited by admin on Fri Dec 15 15:11:46 UTC 2023
|
PRIMARY | |||
|
336279
Created by
admin on Fri Dec 15 15:11:46 UTC 2023 , Edited by admin on Fri Dec 15 15:11:46 UTC 2023
|
PRIMARY | |||
|
3055
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
2MRO291B4U
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
DB00349
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
SUB06673MIG
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
100000084299
Created by
admin on Fri Dec 15 15:11:46 UTC 2023 , Edited by admin on Fri Dec 15 15:11:46 UTC 2023
|
PRIMARY | |||
|
CHEMBL70418
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
8343
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
2MRO291B4U
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
C81615
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
244-908-7
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
Clobazam
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
21241
Created by
admin on Fri Dec 15 15:11:46 UTC 2023 , Edited by admin on Fri Dec 15 15:11:46 UTC 2023
|
PRIMARY | RxNorm | ||
|
m3626
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | Merck Index | ||
|
N0000182137
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | Cytochrome P450 2D6 Inhibitors [MoA] | ||
|
7149
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY | |||
|
682
Created by
admin on Fri Dec 15 15:11:45 UTC 2023 , Edited by admin on Fri Dec 15 15:11:45 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> INDUCER | |||
|
BINDER->LIGAND |
BINDING
|
||
|
EXCRETED UNCHANGED |
FECAL
|
||
|
EXCRETED UNCHANGED |
Clobazam is cleared mainly by metabolism with subsequent renal elimination of metabolites. In a mass balance study, 82% of the dose administered was recovered in the urine and 11% in the feces. Clobazam represents ~2 % of the dose recovered in urine.
URINE
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MINOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
SINGLE- OR MULTIPLE-DOSE ADMINISTRATIONS |
|
||